Key facts
- This page summarizes Robert Dee Etherington's Form 4 filing for Clene Inc. (CLNN).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 01 Oct 2024, 16:17.
Robert Dee Etherington - 30 Sep 2024 Form 4 Insider Report for Clene Inc. (CLNN)
- Reporting relationship
- Chief Executive Officer, Director
- Issuer ticker
- CLNN
- Reported as of
- 30 Sep 2024
- Net transaction value
- +$48,750
- SEC form
- 4
- Accepted by SEC
- 01 Oct 2024, 16:17:06 UTC
- Prior SEC filing
- 19 Aug 2024
- Next SEC filing
- 25 Feb 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Jerry Miraglia POA
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Robert Dee Etherington filed Form 4 for Clene Inc. (CLNN) on 01 Oct 2024.
Change
- Previous filing in this sequence was filed on 19 Aug 2024.
- Current net transaction value: +$48,750.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CLNN
transaction
Common Stock
Purchase
- Transaction value
- $47,500
- Shares
- +10,000
- Change %
- +33%
- Price
- $4.75
- Shares after
- 40,149
- Date
- 30 Sep 2024
- Ownership
- Direct
CLNN
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 636
- Date
- 30 Sep 2024
- Ownership
- By LLC
- Footnotes
- F1
CLNN
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 1,250
- Date
- 30 Sep 2024
- Ownership
- By trust
- Footnotes
- F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
CLNN
transaction
Derivative
Warrants (Right to buy)
Award
- Transaction value
- $1,250
- Shares
- +10,000
- Change %
- Price
- $0.1250
- Shares after
- 10,000
- Date
- 30 Sep 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 10,000
- Exercise price
- $4.82
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
The securities are owned by RDE RX Ventures LLC. Mr. Etherington is the manager of RDE RX Ventures LLC. The shares owned by RDE RX Ventures LLC may also be deemed to be beneficially owned by Mr. Etherington.
Footnote F2
The securities are owned by the Etherington Revocable Trust. Mr. Etherington is the co-trustee of the Etherington Revocable Trust. The shares owned by the Etherington Revocable Trust may be deemed to be beneficially owned by Mr. Etherington.